Today, eVTOL remains a selective market rather than a broad one: on the latest close, Joby finished at $11.90 on 31,381,871 shares, Archer closed at $6.81 on 56,889,622 shares, and EHang ended at $10.16 on 1,235,068 shares. That split in volume and attention matters because investors are clearly paying up for the clearest near-term certification story while still debating whether manufacturing depth or balance-sheet strength deserves a higher multiple.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Is the market still underpricing Joby’s manufacturing readiness?
My read: yes, but only because the market is still valuing Joby as if factory readiness matters less than a visible 2026 revenue line. The underlying operating evidence points the other way. In its first-quarter 2026 results, Joby said it ended the quarter with roughly $2.5 billion of cash, grew composite production more than 2.5 times year over year, flew its first FAA-conforming aircraft, completed the SR3 audit, and was already producing parts not only for the conforming aircraft used in TIA-related work but also for eight additional aircraft components in the build queue (Joby IR). Put differently, investors are no longer looking at a company that merely says industrialization is possible; they are looking at a company that is already paying the cost of industrialization.
That matters because factory readiness is not a cosmetic milestone in aerospace. It determines whether certification, once won, can be translated into actual deployed aircraft rather than into another year of narrative extension. Joby’s manufacturing footprint of nearly 1.5 million square feet and the expansion work in California and Ohio suggest a company building for a fleet, not just for a demo cycle. The way I see it, the market is acknowledging some of that progress, but not enough of it. A stock closing at $11.90 while carrying a multi-billion-dollar cash cushion and tangible production growth suggests investors are still discounting the payoff period very aggressively.
There is still a fair counterargument. Joby’s daily data makes clear that the near-term catalyst stack remains thinner than Archer’s. The latest market snapshot does not show a fresh revenue trigger, and volume, while healthy at 31.4 million shares, still trailed Archer by a wide margin. In a market where the U.S. 10-year Treasury yield was about 4.45% and the effective fed funds reference remained in the mid-3% range, long-duration eVTOL equities are naturally punished when commercialization sits further out because distant cash flows are discounted more heavily (U.S. Treasury; FRED). That macro backdrop explains part of the hesitation, but it does not fully justify treating Joby’s factory build-out as ordinary.
I think the cleaner conclusion is that Joby is being discounted for timing rather than for capability. That is an important distinction. If the company were still short on cash, still speaking in conceptual terms, or still missing certification-adjacent proof points, skepticism would deserve a larger role. Instead, the evidence increasingly says the physical system is real even if the revenue ramp is not here yet. My lean here is constructive: not because the market must reward Joby immediately, but because the current price still looks more cautious than the manufacturing record now warrants.
How tight is Archer’s 2026 operations timeline after Phase 3?
It looks tight enough that investors should treat execution slippage as a live risk, not a footnote. Yahoo Finance reported on May 30 that Archer has completed three of the four FAA type-certification phases for Midnight and is positioning for city-launch planning on the back of that progress (Yahoo Finance). Archer’s own first-quarter 2026 release also reiterated record certification progress and framed initial U.S. operations as expected in 2026 (Archer IR). On the surface, that sounds like a nearly completed regulatory story. In practice, the last stretch is usually where timing risk becomes most visible.
The calendar is the issue. From the end of May to the end of December, Archer has roughly seven months to finish Phase 4, define and communicate the launch-city path, and show that operational readiness is more than a presentation target on paper. ACHR’s close at $6.81 and its 56,889,622-share session volume show why the market still wants to believe. Investors are actively paying for the possibility that Archer becomes the first eVTOL name to convert certification progress into a real operating headline in the United States. High turnover at that scale tells me this is not passive positioning; it is an active trade around milestone compression.
At the same time, the data set for this run still has a missing proof point. FAA certification data was unavailable this run; next check scheduled for 2026-06-01.
That limitation matters because the market is currently leaning on company messaging and secondary media framing rather than on a fresh FAA database confirmation gathered in this cycle. I do not think that invalidates the progress narrative, but it does mean investors are extrapolating from a partially verified regulatory picture. When a company is this close to the finish line, the difference between “advanced” and “completed” is exactly where valuation can swing hardest. It also means the operational pieces after certification matter more than they did six months ago: aircraft availability, partner readiness, launch logistics, and the discipline to turn an approval into an actual service start. My view is cautious but not skeptical: the 2026 operations story remains plausible, yet the buffer for delay is now thin enough that every missed dated milestone will matter more than it did earlier in the year. If Archer names cities and closes the final certification gap soon, the market can keep rewarding the stock. If not, today’s momentum premium will start to look fragile.
Why is ARKX weighting Archer above Joby despite Joby’s larger cash balance?
The simplest answer is that ARKX appears to be paying for a nearer-term catalyst map rather than for the strongest balance sheet in the group today. As of May 28, 2026, StockAnalysis showed ARKX holding Archer at 4.03% or 6,518,756 shares, versus Joby at 2.93% or 2,704,251 shares (StockAnalysis ARKX holdings). That gap is meaningful because Joby, based on the latest company disclosures referenced in the daily files, still carries the larger cash position at roughly $2.5 billion compared with Archer’s $1.78 billion. If investors were ranking these companies mainly by funding durability, Joby would have the cleaner case for an overweight.
Instead, the ETF weight tells a different story. Archer currently offers a sharper event sequence: Phase 3 is done, Phase 4 remains, and a 2026 U.S. operations narrative is still alive. That is a simpler setup for momentum-sensitive capital than Joby’s broader industrial thesis, which asks investors to reward manufacturing depth now in anticipation of monetization later. I think that distinction explains more of the weighting gap than any claim that Archer has permanently overtaken Joby in strategic quality. Archer’s stock also traded almost 57 million shares on the latest close versus about 31 million for Joby, which reinforces the idea that capital is clustering around the cleaner short-term trigger path.
There is also a portfolio-construction logic at work. An innovation ETF is often more willing to overweight the company that can produce the next dramatic milestone, even if the underlying industrial base is less mature. Joby’s evidence base is arguably deeper: more cash, stronger production expansion, a conforming aircraft already flown, and a more visible manufacturing footprint. But deeper does not always mean easier to price in the current market regime. When rates remain elevated and investors want proof that the commercialization clock is truly ticking, the name with the crispest next headline often wins the flow battle. The way I see it, ARKX is not necessarily voting against Joby’s fundamentals; it is voting for Archer’s narrative velocity.
That is why I would frame the current weighting as a momentum preference rather than a settled sector verdict. If Archer converts certification momentum into dated operating proof, the overweight will look disciplined. If Joby’s manufacturing advantage begins to translate into unmistakable deployment readiness before Archer clears the final hurdle, the present gap could look like short-term chasing. My lean here is neutral-to-constructive on the interpretation: ARKX’s positioning says more about what the market wants to trade next than about which company has already won the eVTOL endgame.
What to Watch Tomorrow
- First, watch whether Archer produces any dated FAA or launch-city confirmation that turns a momentum narrative into a verifiable operating timeline.
- Second, watch whether Joby gets fresh investor recognition for production scale, cash strength, or certification-adjacent manufacturing progress rather than being judged only on near-term revenue.
- Third, watch whether ARKX positioning or high-volume trading continues to favor the cleaner short-term certification story over the deeper manufacturing balance-sheet story.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: https://futurewatchlog.com/2026/05/30/evtol-daily-insight-2026-05-30/